CARDIOVASCULAR RISK IN PSORIASIS AND PSORIATIC ARTHRITIS

被引：0
|
作者：
McInnes, Iain [1 ]
机构：
[1] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.8536
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SP0009
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [21] Cardiovascular risk in patients with psoriatic arthritis
    Korotaeva, T. V.
    Novikova, D. S.
    Loginova, E. Yu.
    TERAPEVTICHESKII ARKHIV, 2016, 88 (05) : 102 - 106
  • [22] Cardiovascular risk in patients with psoriatic arthritis
    Nature Reviews Rheumatology, 2015, 11 (3) : 126 - 126
  • [23] Cardiovascular Risk in Patients with Psoriatic Arthritis
    Zhu, Tracy Y.
    Li, Edmund K.
    Tam, Lai-Shan
    INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2012, 2012
  • [24] Cardiovascular risk in patients with psoriatic arthritis
    Soriano, Enrique R.
    Velozo, Edson
    Ceballos, Maria F.
    Rosa, Javier
    Schpilberg, Monica
    Catoggio, Luis J.
    RHEUMATOLOGY, 2008, 47 : II67 - II67
  • [25] The Risk of Venous Thromboembolism in Psoriatic Arthritis, Psoriasis and Rheumatoid Arthritis
    Ogdie-Beatty, Alexis
    Shin, Daniel
    Takeshita, Junko
    ChiesaFuxench, Zelma
    Gelfand, Joel
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [26] Cardiovascular risk age, Framingham Risk and Systematic Coronary Risk Evaluation (SCORE) in patients with psoriasis and psoriatic arthritis
    Tobin, A. -M.
    Fitzgerald, R.
    FitzGerald, O.
    Graham, I.
    Kirby, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E148 - E148
  • [27] CARDIOVASCULAR RISK FACTORS AND CARDIOVASCULAR DISEASE IN PSORIATIC ARTHRITIS
    Hoiberg, H. K.
    Semb, A. G.
    Diamantopoulos, A. P.
    Kavanaugh, A.
    Haugeberg, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1169 - 1169
  • [28] Psoriatic arthritis [Psoriasis arthritis]
    Cauza E.
    Dunky A.
    Wiener Medizinische Wochenschrift, 2006, 156 (21-22) : 587 - 595
  • [29] Are there any differences among psoriasis, psoriatic arthritis and rheumatoid arthritis in terms of metabolic syndrome and cardiovascular risk factors?
    Ozkul, Ozlem
    Yazici, Ayten
    Akturk, Sun S.
    Karadag, Duygu T.
    Isik, Ozlem O.
    Tekeoglu, Senem
    Cefle, Ayse
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2019, 6 (04) : 174 - 178
  • [30] Impact of DMARD Treatment on Risk of Repeat Cardiovascular Events Among Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis
    Sparks, Jeffrey A.
    Lesperance, Tamara
    Accortt, Neil A.
    Solomon, Daniel H.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345